Latest news with #MELVILLE
Yahoo
17-06-2025
- Business
- Yahoo
BioRestorative Announces Share Repurchase Program
MELVILLE, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ('BioRestorative', 'BRTX' or the 'Company') (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced that its Board of Directors has authorized a stock repurchase program under which the Company may repurchase up to $2 million of its outstanding common stock through June 16, 2026. "This share repurchase program reflects our confidence in the strength of our clinical development pipeline and the future outlook of our business,' said Lance Alstodt, Chief Executive Officer of BioRestorative. 'There is no question in our minds that BioRestorative has great science, assets and people. As such, we believe our current share price does not reflect the intrinsic value of the company, particularly in light of our recent clinical and operational progress. Accordingly, we believe this program provides us with an opportunity to enhance long-term shareholder value.' The repurchases may be made from time to time in the open market, through privately negotiated transactions, or by other means in accordance with applicable securities laws. The timing, number, and value of shares repurchased under the program will be at the discretion of the Company's management and will depend on a variety of factors, including market conditions, share price, and other corporate considerations. The share repurchase program may be modified, suspended or terminated at any time at the Company's discretion and does not obligate the Company to acquire any amount of common stock. About BioRestorative Therapies, Inc. BioRestorative ( develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. As described below, our two core clinical development programs relate to the treatment of disc/spine disease and metabolic disorders, and we also operate a commercial BioCosmeceutical platform: • Disc/Spine Program (brtxDISC™): Our lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. We intend that the product will be used for the non-surgical treatment of painful lumbosacral disc disorders or as a complementary therapeutic to a surgical procedure. The BRTX-100 production process utilizes proprietary technology and involves collecting a patient's bone marrow, isolating and culturing stem cells from the bone marrow and cryopreserving the cells. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patient's damaged disc. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. We have also obtained U.S. Food and Drug Administration ('FDA') Investigational New Drug ('IND') clearance to evaluate BRTX-100 in the treatment of chronic cervical discogenic pain. • Metabolic Program (ThermoStem®): We are developing cell-based therapy candidates to target obesity and metabolic disorders using brown adipose (fat) derived stem cells ('BADSC') to generate brown adipose tissue ('BAT'), as well as exosomes secreted by BADSC. BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. Initial preclinical research indicates that increased amounts of brown fat in animals may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes. BADSC secreted exosomes may also impact weight loss. • BioCosmeceuticals: We operate a commercial BioCosmeceutical platform. Our current commercial product, formulated and manufactured using our cGMP ISO-7 certified clean room, is a cell-based secretome containing exosomes, proteins and growth factors. This proprietary biologic serum has been specifically engineered by us to reduce the appearance of fine lines and wrinkles and bring forth other areas of cosmetic effectiveness. Moving forward, we also intend to explore the potential of expanding our commercial offering to include a broader family of cell-based biologic aesthetic products and therapeutics via IND-enabling studies, with the aim of pioneering FDA approvals in the emerging BioCosmeceuticals space. Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including, without limitation, those set forth in the Company's latest Form 10-K, filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements. CONTACT: Stephen KilmerInvestor RelationsDirect: (646) 274-3580 Email: skilmer@
Associated Press
12-06-2025
- Business
- Associated Press
Verint Genie Bot Delivers Millions of Dollars in Business Value
MELVILLE, N.Y.--(BUSINESS WIRE)--Jun 12, 2025-- Verint ® (NASDAQ: VRNT), The CX Automation Company ™, today announced AI business outcomes customers achieved with the recently launched Verint Genie Bot. Part of Verint Open Platform's business analytics solutions, Verint Genie Bot is supercharging business analyst capacity. The bot delivers critical customer experience (CX) insights to executives at unprecedented speed across customer complaints, churn, upsell opportunities and cost reduction initiatives. Verint Genie Bot Delivers Powerful AI Business Outcomes The AI-powered bot delivers actionable CX insights in minutes, driving millions of dollars in value to customers across industries. For example, in the first day of using Verint Genie Bot, an international financial institution uncovered the insights to optimize customer journeys, reduce costs and increase revenue by $5 million. In addition, an energy provider leveraged the bot's insights to streamline self-service and agent workflows, opening the door to $3 million in cost reduction. 'Our latest release of Verint Genie Bot is another breakthrough in applying agentic AI to CX Automation,' said Verint's Global Vice President, Product and Go-to-Market Strategy, Daniel Ziv. 'By combining the latest generative and agentic AI capabilities, Verint Genie Bot is now proven to create unparalleled value.' Discover how Verint Genie Bot and Verint Open Platform can unlock transformative insights and AI outcomes, now. About Verint Verint ® (NASDAQ: VRNT) is a leader in Customer Experience (CX) Automation, serving a customer base that includes more than 80 of the Fortune 100 companies. The world's most iconic brands use the Verint Open Platform and our team of AI-powered bots to deliver tangible AI Business Outcomes, Now™ across the enterprise. Verint is uniquely positioned to help brands increase CX Automation with our differentiated, AI-powered Open Platform. Verint, The CX Automation Company™, is proud to be Certified™ by Great Place To Work ®. Learn more at This press release contains 'forward-looking statements,' including statements regarding expectations, predictions, views, opportunities, plans, strategies, beliefs and statements of similar effect relating to Verint Systems Inc. These forward-looking statements are not guarantees of future performance and they are based on management's expectations that involve a number of risks, uncertainties and assumptions, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. For a detailed discussion of these risk factors, see our Annual Report on Form 10-K for the fiscal year ended January 31, 2025, and other filings we make with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release and, except as required by law, Verint assumes no obligation to update or revise them or to provide reasons why actual results may differ. VERINT, VERINT DA VINCI, VERINT OPEN CCAAS, THE CX AUTOMATION COMPANY, THE CUSTOMER ENGAGEMENT COMPANY AND THE ENGAGEMENT CAPACITY GAP are trademarks of Verint Systems Inc. or its subsidiaries. Verint and other parties may also have trademark rights in other terms used herein. View source version on CONTACT: Media Relations Andi Barnett [email protected] Relations Matthew Frankel [email protected] KEYWORD: UNITED STATES NORTH AMERICA NEW YORK INDUSTRY KEYWORD: PROFESSIONAL SERVICES DATA MANAGEMENT BUSINESS DATA ANALYTICS TECHNOLOGY SOFTWARE ARTIFICIAL INTELLIGENCE SOURCE: Verint Copyright Business Wire 2025. PUB: 06/12/2025 09:47 AM/DISC: 06/12/2025 09:45 AM
Associated Press
20-05-2025
- Business
- Associated Press
Powerhouse Southern Regional Bank Significantly Expands Partnership with Intellicheck
MELVILLE, N.Y.--(BUSINESS WIRE)--May 20, 2025-- Intellicheck, Inc. (Nasdaq: IDN), an industry-leading identity company delivering proprietary on-demand digital and physical identity validation solutions, today announced a top financial customer has signed a new high value three-year agreement. This agreement expands the initial digital use-cases to also include teller workstation transactions. The total contract value in the high seven-figure range is expected to propel this client to a top three revenue generator for the Company. The new agreement significantly expands the bank's utilization of Intellicheck's cutting-edge identity validation technology. This regional bank is now utilizing Intellicheck's technology in their more than 1,900 branches nationwide. The initial Annual Contract Value is anticipated to be a low-seven figure revenue amount paid in equal monthly installments for the first year as the product is rolled out throughout its system. The Total Contract Value is anticipated to be a high seven-figure revenue amount. The Company expects the additional contracted revenue to begin in the third quarter of 2025. Intellicheck CEO Bryan Lewis commented, 'We believe that the growth of this partnership reflects the important role our innovative technology solution delivers as it gives this bank the ability to accelerate customer acquisition and customer protection, while also enhancing bank-customer trust. Good customers benefit from the fraud protection only our unique proprietary technology can provide. We are very excited to significantly expand our relationship and lengthen the contract with this widely recognized regional bank.' Intellicheck's unique technology enables bank branch personnel to rapidly respond to requests for account changes, credit applications, and new account opening requests while at the same time stopping identity theft. Intellicheck's partner is a leading regional U.S. commercial bank. With more than $500 billion in total assets, the bank offers a wide range of consumer and commercial services through its wholesale and consumer businesses including consumer and small business banking, commercial banking, corporate and investment banking payments, and specialized lending businesses. Intellicheck provides both digital and physical identity verification solutions to industries where speed and certainty is crucial. Intellicheck's approach to proving identity is unique. It enables a frictionless customer experience that seamlessly fits into existing workflows using existing technology, scanning devices or Intellicheck's mobile app. Intellicheck's technology solutions provide a proprietary identity verification process that creates a competitive advantage for every business by facilitating rapid customer acquisition and on-going customer retention and trust at the point of service, while preventing unauthorized ID use and stopping identity-based fraud. About Intellicheck Intellicheck, the industry leader in identity verification management, prevents the unauthorized use of IDs to stop identity-based fraud. Intellicheck is the only SaaS-based validation and proofing service that uses a unique and proprietary analysis of DMV-issued IDs to create trusted, real-time customer identity verification experiences across a wide variety of sectors, both in-person and digitally. Each year, we validate around 100 million identities across North America, providing a seamless, invisible ID verification with 100% decisioning in under a second. For more information on Intellicheck, visit us on the web and follow us on LinkedIn, X, Facebook, and YouTube. Safe Harbor Statement Statements in this news release about Intellicheck's future expectations, including: the advantages of our products, future demand for Intellicheck's existing and future products, whether brand value and market awareness will grow, whether the Company can leverage existing partnerships or enter into new ones, and all other statements in this release, other than historical facts, are 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). These statements, which express management's current views concerning future events, trends, contingencies or results, appear at various places in this release and use words like 'anticipate,' 'assume,' 'believe,' 'continue,' 'estimate,' 'expect,' 'forecast,' 'future,' 'intend,' 'plan,' 'potential,' 'predict,' 'project,' 'sense', 'strategy,' 'target' and similar terms, and future or conditional tense verbs like 'could,' 'may,' 'might,' 'should,' 'will' and 'would' are forward-looking statements within the meaning of the PSLRA. This statement is included for the express purpose of availing Intellicheck, Inc. of the protections of the safe harbor provisions of the PSLRA. It is important to note that actual results and ultimate corporate actions could differ materially from those in such forward-looking statements based on such factors as: market acceptance of our products and the presently anticipated growth in the commercial adoption of our products and services; our ability to successfully transition pilot programs into formal commercial scale programs; our ability to successfully implement and monetize new and expanded relationships with clients; continued adoption of our SaaS product offerings; changing levels of demand for our current and future products; our ability to reduce or maintain expenses while increasing sales; our ability to successfully expand the sales of our products and services into new areas including health care and title insurance; customer results achieved using our products in both the short and long term; success of future research and development activities; our ability to successfully market and sell our products, any delays or difficulties in our supply chain coupled with the typically long sales and implementation cycle for our products; our ability to enforce our intellectual property rights; changes in laws and regulations applicable to our products; our continued ability to access government-provided data; the risks inherent in doing business with the government including audits and contract cancellations; liability resulting from any security breaches or product failure, together with other risks detailed from time to time in our reports filed with the SEC. We do not assume any obligation to update the forward-looking information. View source version on CONTACT: Intellicheck Media and Public Relations: Sharon Schultz (302) 539-3747/[email protected] Intellicheck Investor Relations: Gar Jackson (949) 873-2789/[email protected] KEYWORD: UNITED STATES NORTH AMERICA NEW YORK INDUSTRY KEYWORD: TECHNOLOGY MOBILE/WIRELESS FINANCE SECURITY FINTECH BANKING PROFESSIONAL SERVICES SOFTWARE INTERNET SOURCE: Intellicheck, Inc. Copyright Business Wire 2025. PUB: 05/20/2025 08:10 AM/DISC: 05/20/2025 08:09 AM
